SU5416, a VEGF receptor inhibitor and ligand of the AHR, represents a new alternative for immunomodulation
about
Canonical and noncanonical vascular endothelial growth factor pathways: new developments in biology and signal transduction.STAT5a/b contribute to sex bias in vascular disease: A neuroendocrine perspectiveEnvironmental alkylphenols modulate cytokine expression in plasmacytoid dendritic cells.The aryl hydrocarbon receptor is required for induction of p21cip1/waf1 expression and growth inhibition by SU5416 in hepatoma cells.Modeling the Effect of the Aryl Hydrocarbon Receptor on Transplant ImmunityCollagen density regulates xenobiotic and hypoxic response of mammary epithelial cellsActivation of the aryl hydrocarbon receptor by the widely used Src family kinase inhibitor 4-amino-5-(4-chlorophenyl)-7-(dimethylethyl)pyrazolo[3,4-d]pyrimidine (PP2).Hypothesis: neuroendocrine mechanisms (hypothalamus-growth hormone-STAT5 axis) contribute to sex bias in pulmonary hypertension.The aryl hydrocarbon receptor: a novel target for immunomodulation in organ transplantation.Aryl hydrocarbon receptor ligands inhibit igf-ii and adipokine stimulated breast cancer cell proliferationAryl hydrocarbon receptor signaling regulates NF-κB RelB activation during dendritic-cell differentiationRole of the aryl hydrocarbon receptor (AhR) in lung inflammationAllelic variants of the aryl hydrocarbon receptor differentially influence UVB-mediated skin inflammatory responses in SKH1 mice.Role of the Aryl Hydrocarbon Receptor in Sugen 5416-induced Experimental Pulmonary Hypertension.Commentary: Usage of Mitogen-Activated Protein Kinase Small Molecule Inhibitors: More Than Just Inhibition!
P2860
Q27342723-78BF82BC-E6D5-44F6-B4CB-5B4DAE84BCC4Q28081115-9EC78487-C64E-42B0-9382-013853029D86Q31139260-A3D97685-94DE-4182-BE5E-3ADDE5653170Q33648812-EEA7AC96-E031-4F0E-9D86-2D1E91C903E7Q33719835-3A45CB01-2908-47BD-AB73-8C51D2CC9577Q35071054-CEB0911D-57C3-4844-A421-B32D5FC0EC1EQ35680450-02D17054-DF18-4430-9291-8BC42906A2ABQ36568290-C15B3C10-1F93-4A5D-8FB2-414EDDA26784Q36980464-F59ED017-2828-4A76-8426-1DA557E911E8Q37221957-96D679CF-3EC1-47F0-93EB-7BB78DCCDC26Q37250352-D4EE9237-1662-4DBF-8E69-AB5AA772566EQ37292408-24CDB7CB-3F92-4153-B216-30ADA06B4514Q47380108-12148CC4-A4CF-4363-8BA0-9021E3F3A16FQ47731873-D025CFC0-19F7-43D0-8F77-E82004CA9115Q58735041-AC2EB1AB-86B2-4BC4-9D6C-61BDFCF4724E
P2860
SU5416, a VEGF receptor inhibitor and ligand of the AHR, represents a new alternative for immunomodulation
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
SU5416, a VEGF receptor inhibi ...... ternative for immunomodulation
@ast
SU5416, a VEGF receptor inhibi ...... ternative for immunomodulation
@en
SU5416, a VEGF receptor inhibi ...... ternative for immunomodulation
@nl
type
label
SU5416, a VEGF receptor inhibi ...... ternative for immunomodulation
@ast
SU5416, a VEGF receptor inhibi ...... ternative for immunomodulation
@en
SU5416, a VEGF receptor inhibi ...... ternative for immunomodulation
@nl
prefLabel
SU5416, a VEGF receptor inhibi ...... ternative for immunomodulation
@ast
SU5416, a VEGF receptor inhibi ...... ternative for immunomodulation
@en
SU5416, a VEGF receptor inhibi ...... ternative for immunomodulation
@nl
P2093
P2860
P1433
P1476
SU5416, a VEGF receptor inhibi ...... ternative for immunomodulation
@en
P2093
Christopher A Bradfield
Greg Kennedy
John H Fechner
Joshua D Mezrich
Linh P Nguyen
Manabu Nukaya
Xiaoji Zhang
Yongna Xing
P2860
P304
P356
10.1371/JOURNAL.PONE.0044547
P407
P577
2012-01-01T00:00:00Z